Variant report

Variant	esv11876
Chromosome Location	chr14:105400671-105419692
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:27)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:4)

No data

(count:27 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr14:105361378..105363215-chr14:105404898..105407552,2	K562	blood:
2	chr14:105375706..105377336-chr14:105399096..105400699,2	MCF-7	breast:
3	chr14:105365193..105367745-chr14:105399799..105401436,2	K562	blood:
4	chr14:105399483..105402053-chr14:105402231..105403735,2	MCF-7	breast:
5	chr14:105398736..105403202-chr14:105431579..105436953,6	MCF-7	breast:
6	chr14:105402552..105405090-chr14:105425652..105427842,2	K562	blood:
7	chr14:105393329..105396153-chr14:105398779..105401055,3	MCF-7	breast:
8	chr14:105399483..105402053-chr14:105402231..105403735,2	MCF-7	breast:
9	chr14:105402513..105405385-chr14:105405558..105407496,3	K562	blood:
10	chr14:105399205..105401135-chr14:105489654..105492411,2	MCF-7	breast:
11	chr14:105363028..105363697-chr14:105406799..105407525,3	MCF-7	breast:
12	chr14:105293691..105294557-chr14:105406827..105407640,3	MCF-7	breast:
13	chr14:105284508..105286639-chr14:105398983..105401312,2	MCF-7	breast:
14	chr14:105234995..105235860-chr14:105406869..105407692,2	MCF-7	breast:
15	chr14:105399113..105400840-chr14:105456852..105459297,2	K562	blood:
16	chr14:105402462..105404060-chr14:105435973..105438203,2	MCF-7	breast:
17	chr14:105292002..105293559-chr14:105403118..105405949,2	MCF-7	breast:
18	chr14:105405873..105407482-chr14:105449150..105451992,2	MCF-7	breast:
19	chr14:105402668..105405170-chr14:105443237..105446024,2	K562	blood:
20	chr14:105402513..105405385-chr14:105405558..105407496,3	K562	blood:
21	chr14:105398840..105402135-chr14:105423492..105426295,4	MCF-7	breast:
22	chr14:105362730..105363610-chr14:105406815..105407855,5	MCF-7	breast:
23	chr14:105419320..105427156-chr14:105428137..105437324,13	MCF-7	breast:
24	chr14:105402645..105404186-chr14:105423376..105425960,2	MCF-7	breast:
25	chr14:105406835..105407618-chr14:105511905..105512554,2	MCF-7	breast:
26	chr14:105398451..105401348-chr14:105403899..105406455,2	K562	blood:
27	chr14:105404478..105406291-chr14:105429556..105431911,2	K562	blood:

No data

(count:4 , 50 per page) page: 1

No.	miRNA target gene	miRNA name	Chromosome Location
1	AHNAK2	hsa-miR-16-5p	chr14:105403985-105403979
2	AHNAK2	hsa-miR-16-5p	chr14:105403979-105403973
3	AHNAK2	hsa-miR-16-5p	chr14:105403979-105404000
4	AHNAK2	hsa-miR-16-5p	chr14:105403982-105403976

Variant related genes	Relation type
ENSG00000185567	chromatin interactions
ENSG00000258430	chromatin interactions
ENSG00000166428	chromatin interactions
ENSG00000140104	chromatin interactions

Extended variants
information (count: 2518 )
Associated
traits (count: 108 )

Variant overlapped rSNPs/rCNVs (count:2518 , 50 per page) page: 1 2 3 4 5 6 7 ... 51

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs559134860	chr14:105400672-105400673	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Active TSS Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs181361969	chr14:105400694-105400695	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Active TSS Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs544308093	chr14:105400695-105400696	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Active TSS Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs561300803	chr14:105400713-105400714	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Active TSS Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs574665412	chr14:105400723-105400724	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Active TSS Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs201260241	chr14:105400806-105400807	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs540473236	chr14:105400810-105400811	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs149496537	chr14:105400911-105400912	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs72702018	chr14:105400964-105400965	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs548160918	chr14:105400967-105400968	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs59844334	chr14:105401068-105401069	Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs148620865	chr14:105401093-105401094	Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs186507079	chr14:105401101-105401102	Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs74603289	chr14:105401180-105401181	Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs371539873	chr14:105401228-105401229	Weak transcription Enhancers Bivalent Enhancer Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs547895995	chr14:105401266-105401267	Weak transcription Enhancers Bivalent Enhancer Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs568023852	chr14:105401346-105401347	Weak transcription Enhancers Bivalent Enhancer Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs113022727	chr14:105401350-105401351	Weak transcription Enhancers Bivalent Enhancer Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs536550341	chr14:105401443-105401444	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs112814772	chr14:105401469-105401470	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs547233276	chr14:105401488-105401489	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs79371214	chr14:105401506-105401507	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs370495651	chr14:105401507-105401508	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs539286390	chr14:105401617-105401618	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
25	rs190694855	chr14:105401649-105401650	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
26	rs117774822	chr14:105401657-105401658	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs538309213	chr14:105401702-105401703	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
28	rs182901921	chr14:105401754-105401755	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
29	rs113832064	chr14:105401820-105401821	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
30	rs74646630	chr14:105401946-105401947	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
31	rs144218762	chr14:105401966-105401967	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
32	rs187243348	chr14:105401977-105401978	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
33	rs376656679	chr14:105402071-105402072	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
34	rs79764956	chr14:105402085-105402086	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
35	rs115123726	chr14:105402145-105402146	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
36	rs190958509	chr14:105402153-105402154	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
37	rs368911958	chr14:105402182-105402183	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
38	rs549727511	chr14:105402236-105402237	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
39	rs548222879	chr14:105402312-105402313	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
40	rs561541439	chr14:105402314-105402315	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
41	rs80187360	chr14:105402329-105402330	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
42	rs547076073	chr14:105402370-105402371	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
43	rs567200174	chr14:105402416-105402417	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
44	rs539325011	chr14:105402417-105402418	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
45	rs10083490	chr14:105402418-105402419	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
46	rs376431475	chr14:105402449-105402450	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs554505148	chr14:105402469-105402470	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs144884195	chr14:105402573-105402574	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs537960989	chr14:105402580-105402581	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs533979030	chr14:105402588-105402589	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:108)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Retinoblastoma	21504564	CNVD
High-proliferative meningiomas	17937814	CNVD
Non-small cell lung cancer	21044232	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Melanoma	18172304	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Medulloblastoma	21979893	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Neuroblastoma	19435921	CNVD
Colorectal cancer	19359472	CNVD
Breast cancer	17899364	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Renal cell carcinoma	21668985	CNVD
Chronic myeloid leukemia	20724749	CNVD
Wilms tumour	21544195	CNVD
Lung cancer	18438408	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Colorectal cancer	16774939	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Neuroblastoma	18923191	CNVD
Barrett''s syndrome	19417022	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
cataract	16735990	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Developmental delay	21147756	CNVD
Cancer	20164920	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Biliary cancer	19435499	CNVD
Follicular lymphoma	20505157	CNVD
Acute lymphoblastic leukemia	20139093	CNVD
Hepatocellular carcinoma	16750200	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Glioblastoma multiforme	21922591	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Ovarian cancer	22174824	CNVD
Non-small cell lung cancer	18320023	CNVD
Melanoma	17363583	CNVD
Prostate cancer	18632612	CNVD
Congenital heart defect	22367666	CNVD
Developmental delay	22367666	CNVD
Genitourinary abnormalities	22367666	CNVD
Intellectual disability	22367666	CNVD
Microcephaly	22367666	CNVD
Muscularhypotonia	22367666	CNVD
Ocular coloboma	22367666	CNVD
Teratozoospermia	22367666	CNVD
Cervical cancer	21062161	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Breast cancer	21990379	CNVD
Breast cancer	16417655	CNVD
22q11 deletion syndrome	22511897	CNVD
Cancer	21129771	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Schizophrenia	21399695	CNVD
Intracranial ependymoma	16609018	CNVD
Lung adenocarcinoma	17086460	CNVD
Gastric adenocarcinoma	19115996	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
14q deletion syndrome	22511897	CNVD
Epilepsy	22083797	CNVD
Urothelial carcinoma	21177765	CNVD
Ovarian cancer	21720365	CNVD
Cancer	17440070	CNVD
Neurocytoma	17123091	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Central neurocytomas	17123091	CNVD
Acute lymphoblastic leukemia	17315016	CNVD
Lung cancer	17086460	CNVD
Mortal	21835882	CNVD
Breast cancer	21364760	CNVD
small cell lung cancer	17426248	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Schizophrenia	20967226	CNVD
early-passage human iPS cells	21368824	CNVD
Williams Syndrome	20824207	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Pancreatic cancer	17952125	CNVD
Schizophrenia	23813976	CNVD
lymphocytic leukemia	21291569	CNVD
Cancer	20164919	CNVD
small cell lung cancer	20016488	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD
Acute lymphoblastic leukemia	22237106	CNVD

Chromatin state (count:240 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr14:105398400-105400800	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
2	chr14:105398800-105400800	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
3	chr14:105398800-105400800	Active TSS	Brain Angular Gyrus	brain
4	chr14:105399200-105400800	Bivalent/Poised TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
5	chr14:105399400-105401000	Active TSS	Stomach Smooth Muscle	stomach
6	chr14:105399600-105400800	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
7	chr14:105399600-105406800	Weak transcription	Spleen	Spleen
8	chr14:105399800-105404400	Weak transcription	A549	lung
9	chr14:105399800-105405800	Weak transcription	Brain Substantia Nigra	brain
10	chr14:105399800-105405800	Weak transcription	HMEC	breast
11	chr14:105399800-105410800	Weak transcription	Primary B cells from cord blood	blood
12	chr14:105399800-105413800	Weak transcription	Placenta Amnion	Placenta Amnion
13	chr14:105399800-105419800	Weak transcription	Duodenum Smooth Muscle	Duodenum
14	chr14:105399800-105424000	Weak transcription	Hela-S3	cervix
15	chr14:105399800-105425000	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
16	chr14:105400000-105400800	Enhancers	Primary hematopoietic stem cells	blood
17	chr14:105400000-105400800	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
18	chr14:105400000-105400800	Weak transcription	Pancreas	Pancrea
19	chr14:105400400-105400800	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
20	chr14:105400400-105400800	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
21	chr14:105400400-105400800	Flanking Active TSS	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
22	chr14:105400400-105400800	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
23	chr14:105400400-105400800	Flanking Bivalent TSS/Enh	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
24	chr14:105400400-105400800	Bivalent Enhancer	H9 Derived Neuron Cultured Cells	ES cell derived
25	chr14:105400400-105400800	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
26	chr14:105400400-105400800	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
27	chr14:105400400-105400800	Bivalent Enhancer	Primary hematopoietic stem cells short term culture	blood
28	chr14:105400400-105400800	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin02	Skin
29	chr14:105400400-105400800	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin03	Skin
30	chr14:105400400-105400800	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
31	chr14:105400400-105401000	Enhancers	Esophagus	oesophagus
32	chr14:105400400-105401000	Bivalent Enhancer	Fetal Muscle Leg	muscle
33	chr14:105400400-105401200	Bivalent Enhancer	Fetal Stomach	stomach
34	chr14:105400400-105401400	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
35	chr14:105400400-105402000	Enhancers	Breast Myoepithelial Primary Cells	Breast
36	chr14:105400600-105400800	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
37	chr14:105400600-105400800	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
38	chr14:105400600-105400800	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
39	chr14:105400600-105400800	Flanking Bivalent TSS/Enh	iPS DF 6.9 Cell Line	embryonic stem cell
40	chr14:105400600-105400800	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
41	chr14:105400600-105400800	Flanking Bivalent TSS/Enh	Primary T helper naive cells fromperipheralblood	blood
42	chr14:105400600-105400800	Bivalent Enhancer	Primary T helper 17 cells PMA-I stimulated	--
43	chr14:105400600-105400800	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
44	chr14:105400600-105400800	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Male	--
45	chr14:105400600-105400800	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
46	chr14:105400600-105400800	Bivalent Enhancer	Ganglion Eminence derived primary cultured neurospheres	brain
47	chr14:105400600-105400800	Flanking Bivalent TSS/Enh	Foreskin Melanocyte Primary Cells skin01	Skin
48	chr14:105400600-105400800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
49	chr14:105400600-105400800	Bivalent Enhancer	Primary mononuclear cells fromperipheralblood	Blood
50	chr14:105400600-105400800	Flanking Bivalent TSS/Enh	Adipose Nuclei	Adipose

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links